Kyntra Bio
KYNB
140 hedge funds and large institutions have $661M invested in Kyntra Bio in 2016 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 52 increasing their positions, 34 reducing their positions, and 13 closing their positions.
62% more first-time investments, than exits
New positions opened: 21 | Existing positions closed: 13
53% more repeat investments, than reductions
Existing positions increased: 52 | Existing positions reduced: 34
5% more funds holding
Funds holding: 133 → 140 (+7)
1.95% more ownership
Funds ownership: 0% → 1.95% (+2%)
8% more call options, than puts
Call options by funds: $5.5M | Put options by funds: $5.08M
4% more capital invested
Capital invested by funds: $637M → $661M (+$23.8M)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$12.9M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$11.1M |
| 3 |
HIM
Hillhouse Investment Management
Grand Cayman,
Cayman Islands
|
+$9.73M |
| 4 |
PC
PointState Capital
New York
|
+$8.52M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$5.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WRF
Waddell & Reed Financial
Overland Park,
Kansas
|
-$36.9M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
-$15M |
| 3 |
TAAM
Top Ace Asset Management
Hong Kong
|
-$5.12M |
| 4 |
UBS AM
Chicago,
Illinois
|
-$4.77M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3.92M |
KYNB Hedge Fund Activity: Q4 2016 in Review
140 of the 4,007 institutional investors tracked by Wall St. Rank reported a position in Kyntra Bio (KYNB) for Q4 2016, worth a combined $661M — up 3.7% from $637M a quarter earlier.
Buyers outnumbered sellers: 21 funds opened new KYNB positions and 13 closed out — a net gain of 8 holders — while 52 added to existing stakes and 34 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $12.9M. The largest seller was Waddell & Reed Financial, exiting entirely with an estimated $36.9M sold.
- 140 institutional investors held Kyntra Bio (KYNB) as of Q4 2016, up from 133 in Q3 2016.
- Funds reported $661M of Kyntra Bio stock for Q4 2016, up 3.7% quarter-over-quarter.
- 21 funds opened new Kyntra Bio positions in Q4 2016 and 13 closed out, a net change of +8 holders.
- The largest Kyntra Bio buyer in Q4 2016 was Fidelity Investments, an estimated $12.9M added.
- The largest Kyntra Bio seller in Q4 2016 was Waddell & Reed Financial, an estimated $36.9M sold.
Based on aggregated 13F filings for Q4 2016.